A $4 million National Cancer Institute grant will help Cleveland Clinic mathematical oncologist Jacob Scott, MD, DPhil, study how ecological and evolutionary mechanisms contribute to lung cancer development, progression and drug resistance.
Pioneering Trial Targets Multiple Solid-Tumor Cancers With Precision Medicine
An innovative nationwide clinical trial will test the efficacy of matching a tumor’s molecular profile to targeted agents to treat patients with advanced solid tumors or lymphomas.